Wed 21 Oct 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Study Title | Study Sponsor | Status | Study Drug | Trial Phase | Study Protocol Number | Site |
|---|---|---|---|---|---|---|
| Registry of treatment patterns in patients with metastatic castration-resistant prostate cancer (mCRPC) with progression during or after DOCETAXEL-based regimen | Sanofi | Ongoing | N/A | 4 | DRIEG_C_05756 | King Fahad Medical City (Riyadh), King Fahad Specialist Hospital (Dammam) |
| Effect of ACS Patients' Education on Adherence to Dual Anti-platelet Therapy (unstable angina + non ST elevation MI + ST elevation MI) | Sanofi | Ongoing | N/A | 4 | DIREG_L_05229 | Dr. Soliman Fakeeh Hospital (Jeddah) |
| An observational Study to evaluate the behaviour of physicians focusing on the preference patterns (reasons to prescribe) of ARB/HCTZ combinations containing high dose (25mg) diuretic for treatment of hypertension in Saudi Arabia | Sanofi | Ongoing | N/A | 4 | IRBEH_L_05674 | King Khalid University Hospital (Riyadh) |
| Study of clinical and non clinical predictive factors for achieving glycemic control in people with type 2 diabetes in real clinical practice | Sanofi | Ongoing | Lantus®/Apidra® | 4 | LANTUR06314 | Dr. Erfan & Bagedo General Hospital (Jeddah) |
| Phase IV, Multicenter, International, Non-comparative, Open Label Study of Efficacy and Safety of Basal Bolus Therapy (Insulin Glargine + Insulin Glulisine) in Patients With T1 Diabetes Previously Uncontrolled on Any Insulin Regimen. | Sanofi | Ongoing | Lantus® + Apidra® | 4 | LANTU_R_05033 | King Khalid University Hospital (Riyadh) |
| multinational observational study on clinical practices and therapeutic management of mineral and bone disorders in chronic kidney disease 4, 5 & 5D | Sanofi | Ongoing | N/A | 4 | OBS13593 | Saudi center for organ transplantation (Riyadh), King Fahad Hospital (Jeddah) |
| Registry on the use of Lactic acid (Lactacyd) in minor gynecologyical conditions among Middle Eastren women | Sanofi | Ongoing | LACTOSERUM LACTIC ACID | 4 | LACACL06308 | Dr. Erfan & Bagedo General Hospital (Jeddah) |
| An Observational, Cross-sectional Study on the Prevalence of Chronic Obstructive Pulmonary Disease (COPD) in adult Population within the MENA Region. | GSK | Ongoing | N/A | 4 | Version 2.1 - 30/08/2009 | Prince Sultan Military Medical City (Riyadh) |
| Clinical Outcomes on ErbB2+ MBC Patients Treated With Lapatinib-Capecitabine After Trastuzumab Progression: Role of Early Versus Late Switch to Lapatinib-Capecitabine (TYCO) | GSK | Ongoing | Lapatinib / Capecitabine | 4 | 113780 | King Abdulaziz Medical City NG (Riyadh) , King Faisal Specialist Hospital and Research Center (Riyadh), King Abdulaziz Hospital and Oncology Center (Jeddah) |
| Randomized Controlled Open Label Trial of Peg Alpha 2a Interferon and Adjusted-dose of Ribavirin vs. Standard Therapy in the Treatment of Naive Chronic Hepatitis C Patients Infected With Genotype 4 | Roche | Ongoing | Pegasys | 3 | ML22728 | King Abdulaziz Medical City NG (Riyadh) |
Last update date: 06/10/2026 at 08:14 AM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.